Zymeworks Inc. (ZYME) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. This is the conference operator. Welcome to Zimework's first quarter 2024 results conference call and webcast. As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. To ask a question, press star 1 1 on your telephone keypad. To withdraw your question, please press star 1 1 again. I would now like to turn the conference over to Srinal Inupdar, Director of Investor Relations. Srinal, please go ahead. Thank you, Operator. Good afternoon. I'd like to welcome you to our first quarter 2024 results conference call. Before we begin, I'd like to remind you that we'll be making a number of forward-looking statements during this call, including, without limitation, those forward-looking statements identified in our slides and the accompanying oral commentary. Board-looking statements are based upon our current expectations and various assumptions and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development. For discussion of these risks and uncertainties, we refer you to our latest SEC filings as found on our website and as filed with the SEC. In a moment, I'll hand the call over to Ken Galbraith, our Chair and Chief Executive Officer. we'll be discussing recent corporate updates along with our financial results for the first quarter of 2024. Following this, Dr. Paul Moore, our Chief Scientific Officer, will talk about recent data shared at the annual American Association for Cancer Research, or AACR, meeting and key takeaways. At the end of the call, Ken, Paul and Bijal Desai, our VP of Finance and Strategy, will be available for Q&A. As a reminder, the audio and slides from t...